In a phase III clinical trial of Dosaxin, a new drug, patients…

In a phase III clinical trial of Dosaxin, a new drug, patients received a progressively growing dosage of Dosaxin for a few days. On the first day, each patient received 15 milligrams of Dosaxin. On each of the following days, the daily dosage was m milligrams greater than the dosage received the day before, reaching a dosage of 43 milligram on the last day of the trial. For how many days did the trial last, if each patient received a total amount of 145 milligrams of Dosaxin during the whole trial ?

AQuA-RAT — Algebra Question Answering with Rationales (Ling et al., DeepMind, 2017) · train #32125